Interesting facts
Interesting Facts About (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-(4-methylpiperazin-1-yl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
This compound, with its intricate structure and diverse functional groups, is a fascinating example of modern medicinal chemistry. One of the most significant features of this compound is:
- Stereochemistry: The compound possesses multiple chiral centers, which contribute to its unique three-dimensional conformation, potentially influencing its biological activity.
- Hydroxyl Groups: The presence of dihydroxy groups suggests that this compound might engage in hydrogen bonding, increasing its solubility in polar environments and enhancing its interaction with biological targets.
- Piperazine moiety: The incorporation of a 4-methylpiperazine group reflects its potential for enhancing pharmacological properties, particularly in shaping the compound's affinity for specific receptors.
- Dimethylation: The addition of dimethyl groups not only affects hydrophobicity but may also contribute to the compound's ability to penetrate cell membranes, which is crucial for its therapeutic effectiveness.
Moreover, researchers are keen on exploring such compounds due to their potential therapeutic applications. The structural complexity paired with varied functional groups often leads to interesting biological activities, such as:
- Anticancer activity
- Neuroprotective effects
- Antidepressant properties
In the pursuit of drug development, compounds like this serve as valuable leads for creating more effective and targeted therapies. As scientists continue to dissect the characteristics and effects of this compound, it remains a testament to the intricate relationship between chemical structure and biological function.
Synonyms
Mazipredone
Mazipredona
13085-08-0
Mazipredone [INN]
Mazipredonum
UNII-QN0W2YSW63
QN0W2YSW63
Mazipredone (INN)
MAZIPREDONE [MI]
MAZIPREDONE [MART.]
MAZIPREDONE [WHO-DD]
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-(4-methylpiperazin-1-yl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
11beta,17-Dihydroxy-21-(4-methyl-1-piperazinyl)pregna-1,4-diene-3,20-dione
MAZIPREDONE (MART.)
11.BETA.,17-DIHYDROXY-21-(4-METHYL-1-PIPERAZINYL)PREGNA-1,4-DIENE-3,20-DIONE
methylpiperazinyl deoxyprednisolone
SCHEMBL25720
CHEMBL2106858
DTXSID30926941
CHEBI:135721
deoxymethyl-piperazinyl prednisolone
AKOS025290378
NS00120900
D08158
Q1175198
11beta,17-dihydroxy-21-(4-methyl-1-piperazinyl)pregna-1,4- diene-3,20-dione
11beta,17-Dihydroxy-21-(4-methyl-1-piperazinyl)pregna-1,4-diene-3,20-dione.
Solubility Characteristics of C22H29FO5
The compound with the formula C22H29FO5 presents interesting challenges regarding its solubility properties. Understanding the solubility of such complex molecules is essential for applications in pharmaceuticals and chemical formulations.
Factors Influencing Solubility
The solubility of this compound can be influenced by various factors, including:
Potential Solubility Behavior
While specific experimental data may be necessary to fully understand its solubility in various solvents, we can indicate possible behavior:
In conclusion, determining the solubility of C22H29FO5 necessitates a comprehensive evaluation taking into account the various structural features and solvent interactions, making it a fascinating subject for further study in the field of chemistry.